Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
A STTR Phase I contract was awarded to Rxbio, Inc in September, 2020 for $252,128.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | STTR | 1R41DK125208-01 | Phase I | 252,128 | September 18, 2020 | |||||||
A SBIR Phase I contract was awarded to Rxbio, Inc in September, 2015 for $222,829.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43DK105719-01A1 | Phase I | 222,829 | September 17, 2015 | |||||||
A SBIR Phase I contract was awarded to Rxbio, Inc in March, 2015 for $297,087.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI118004-01 | Phase I | 297,087 | March 1, 2015 | |||||||
A SBIR Phase I contract was awarded to Rxbio, Inc for $97,162.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43CA126603-01A1 | Phase I | 97,162 | ||||||||
A SBIR Phase I contract was awarded to Rxbio, Inc for $99,977.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43CA130424-01A1 | Phase I | 99,977 | ||||||||
A SBIR Phase I contract was awarded to Rxbio, Inc for $194,797.0 USD from the U.S. Department of Health & Human Services. | SBIR | N43CO110036 | Phase I | 194,797 |